April 14, 2016
Several well-capitalized public patent assertion entities (PAEs) are thriving, but public PAEs, generally, have weathered a tough year. Our RPX Q4 2015 Public PAE Report notes that many public PAEs are low on cash and are buying fewer portfolios.
Read more
January 4, 2016
Our RPX 2015 NPE Activity: Highlights report offers a first look at data for the year on NPE litigation, portfolios offered for sale, and related trends.
Read more
December 10, 2015
Public PAEs have continued to struggle with depressed revenues and fewer financings and portfolio purchases, according to the latest data in our RPX Q3 2015 Public PAE Report.
Read more